Beam Therapeutics Inc. BEAM
26.33 USD +0.46 (+1.78%)
At closeNov 3, 2026, 4:01 PM EST
26.33 0.00 0.00%
After hours · Nov 3, 4:01 PM ET
25.99 Day range 27.20
20.23 52-week range 38.26
- YTD
- -5.01%
- 1 year
- +8.58%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 49.38 +87.6% upside
Now 26.33
- Target (low)
- 26.00
- Target (mean)
- 49.38
- Target (high)
- 80.00
Ratings (0m) 15 13 buy · 2 hold · 0 sell
- Strong buy1
- Buy12
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 15
- 1 month ago 15
- 2 months ago 15
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.19 | -1.34 – -1.06 | 2.33 | -151.0% | 9.74M | -91.5% | 13 |
| Next quarter | -1.21 | -1.28 – -1.14 | -0.91 | -33.0% | 5.50M | -82.7% | 2 |
| Current year | -4.40 | -4.76 – -3.67 | -0.81 | -443.6% | 53.22M | -61.9% | 15 |
| Next year | -4.71 | -5.72 – -3.56 | -4.40 | -7.0% | 60.92M | +14.5% | 14 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 29, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 28, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Oct 15, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 14, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Sep 9, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Aug 25, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 8, 2026 | B of A Securities | Reiterated | Buy | Buy |
| Jul 7, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 13, 2026 | Bernstein | Maintained | Outperform | Outperform |
| Mar 26, 2026 | Citigroup | Maintained | Buy | Buy |
| Feb 25, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Feb 25, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Feb 20, 2026 | Canaccord Genuity | Initiated | — | Buy |
| Jan 21, 2026 | Bernstein | Maintained | Outperform | Outperform |
| Jan 7, 2026 | UBS | Initiated | — | Neutral |
| Nov 24, 2025 | Evercore ISI Group | Initiated | — | Outperform |
| Oct 10, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 9, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Sep 15, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 6, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| May 7, 2025 | Guggenheim | Maintained | Buy | Buy |
| May 7, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| May 7, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Apr 7, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 28, 2025 | B of A Securities | Upgrade | Neutral | Buy |
| Mar 12, 2025 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Mar 10, 2025 | Scotiabank | Upgrade | Sector Perform | Sector Outperform |
| Mar 10, 2025 | Jones Trading | Upgrade | Hold | Buy |
| Mar 10, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 3, 2025 | Scotiabank | Maintained | Sector Perform | Sector Perform |